SMPDL3B and diabetic retinopathy: This finding provides a new target for the treatment of diabetic retinopathy (DR), but the changes in the expression of ZDHHC5, a key enzyme that regulates the palmitoylation of SMPDL3B, in patients with DR need to be further verified (183).